First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership

Submitted by admin on January 4, 2023 - 9:26am

Source:

Fierce Biotech

News Tags:

Mayo Clinic

Mayflower Bioventures

accelerators

Primera Therapeutics

mitochondrial disorders

Headline:

First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership

snippet:

Seeds from Mayo Clinic’s cell and gene therapy accelerator Mayflower Bioventures have taken flight in a new biotech called Primera Therapeutics, which launches today with a blossoming $750 million partnership to work on therapies for mitochondrial diseases.

Search form

You are here

First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership

First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership